Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy

Jing Shi(Chinese People's Liberation Army), Dechang Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Journal for ImmunoTherapy of Cancer
September 11, 2019
Cited by 35


Related Papers